In addition, patients with larger tumors (>3 cm) or lymph node metastasis displayed significantly higher FHL2 levels compared to those with smaller tumors or no metastasis (Fig. 2, C and D). Here, FHL2 is linked to metastatic malignant neoplasm in the lymph nodes.